Preventing relapse in bipolar disorder.
D018692:Antimanic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D018020:Lithium Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D055502:Secondary Prevention; D017211:Treatment Failure; D014635:Valproic Acid / Q000627:therapeutic use*
D018692:Antimanic Agents; D018020:Lithium Compounds; D014635:Valproic Acid